Stock Events

Stock Events

SK Biopharmaceuticals. (326030.KQ) Q3 2025 Earnings

5AugConfirmed

Q4 2024

Q1 2025

Q2 2025

Q3 2025

85

829

1,573

2,318

Details

Expected EPS

397

Actual EPS

384

Surprise EPS

-14

Surprise Percent

+3.43%

Description

SK Biopharmaceuticals. (326030.KQ) has reported earnings of 384 per share for Q3 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.